UNITED LAB Issues Profit Warning, Anticipates 2025 Earnings to Drop to Around 2 Billion Yuan

Stock News03-12

UNITED LAB (03933) has announced that the group expects to achieve a profit of approximately 2 billion yuan in 2025, compared to a profit of about 2.658 billion yuan in 2024. The decrease in profit is primarily due to a decline in market prices for intermediate products and active pharmaceutical ingredients (APIs) during the year. This has led to a reduction in segment profit for both intermediate products and APIs, falling by roughly 1.6 billion yuan and 400 million yuan respectively compared to 2024. However, the profit from the formulated products segment saw a significant increase of about 1.4 billion yuan. This improvement was largely driven by licensing fee revenue of approximately 1.3 billion yuan from Novo Nordisk A/S, which partially offset the profit decline in the intermediate and API segments.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1181027229?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-12 18:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1181027229","market":"other","top_or_hot":-1,"title":"UNITED LAB Issues Profit Warning, Anticipates 2025 Earnings to Drop to Around 2 Billion Yuan","media":"Stock News","content":"<p>UNITED LAB (03933) has announced that the group expects to achieve a profit of approximately 2 billion yuan in 2025, compared to a profit of about 2.658 billion yuan in 2024. The decrease in profit is primarily due to a decline in market prices for intermediate products and active pharmaceutical ingredients (APIs) during the year. This has led to a reduction in segment profit for both intermediate products and APIs, falling by roughly 1.6 billion yuan and 400 million yuan respectively compared to 2024. However, the profit from the formulated products segment saw a significant increase of about 1.4 billion yuan. This improvement was largely driven by licensing fee revenue of approximately 1.3 billion yuan from Novo Nordisk A/S, which partially offset the profit decline in the intermediate and API segments.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UNITED LAB Issues Profit Warning, Anticipates 2025 Earnings to Drop to Around 2 Billion Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUNITED LAB Issues Profit Warning, Anticipates 2025 Earnings to Drop to Around 2 Billion Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-03-12 18:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>UNITED LAB (03933) has announced that the group expects to achieve a profit of approximately 2 billion yuan in 2025, compared to a profit of about 2.658 billion yuan in 2024. The decrease in profit is primarily due to a decline in market prices for intermediate products and active pharmaceutical ingredients (APIs) during the year. This has led to a reduction in segment profit for both intermediate products and APIs, falling by roughly 1.6 billion yuan and 400 million yuan respectively compared to 2024. However, the profit from the formulated products segment saw a significant increase of about 1.4 billion yuan. This improvement was largely driven by licensing fee revenue of approximately 1.3 billion yuan from Novo Nordisk A/S, which partially offset the profit decline in the intermediate and API segments.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03933","symbol_name":"联邦制药","start_time":0,"source_url":"","article_id":"1181027229","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1181027229","pubTimestamp":1773310449,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"UNITED LAB (03933) has announced that the group expects to achieve a profit of approximately 2 billion yuan in 2025, compared to a profit of about 2.658 billion yuan in 2024. The decrease in profit...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03933":"联邦制药","BK1191":"制药"},"translate_title":"联邦制药发布盈利预警预计2025年盈利降至20亿元左右","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03933":1},"content_text":"UNITED LAB (03933) has announced that the group expects to achieve a profit of approximately 2 billion yuan in 2025, compared to a profit of about 2.658 billion yuan in 2024. The decrease in profit is primarily due to a decline in market prices for intermediate products and active pharmaceutical ingredients (APIs) during the year. This has led to a reduction in segment profit for both intermediate products and APIs, falling by roughly 1.6 billion yuan and 400 million yuan respectively compared to 2024. However, the profit from the formulated products segment saw a significant increase of about 1.4 billion yuan. This improvement was largely driven by licensing fee revenue of approximately 1.3 billion yuan from Novo Nordisk A/S, which partially offset the profit decline in the intermediate and API segments.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1181027229","isCrawlerRequest":true}